Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC22A1 | O15245 | 4/20 | 0.67 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | TP53 | P04637 | 1/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.52 |
| ▸ | DNM1 | Q05193 | 6/20 | 0.48 |
| ▸ | LSS | P48449 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tetrapentylammonium SCHEMBL10909204 | 0.94 | SLC22A1 (0.67) | SLC22A1SLC22A2ALDH1A1TP53CYP3A4 | |
| Tetrahexylammonium SCHEMBL10909488 | 0.92 | SLC22A1 (0.68) | SLC22A1SLC22A2ALDH1A1TP53CYP3A4 | |
| Tetrabuthylammonium SCHEMBL15822811 | 0.86 | SLC22A1 (0.71) | SLC22A1SLC22A2ALDH1A1TP53CYP3A4 | |
| Tetrabuthylammonium SCHEMBL5687676 | 0.85 | SLC22A1 (0.92) | SLC22A1SLC22A2ALDH1A1TP53CYP3A4 | |
| Tetrabuthylammonium SCHEMBL1204718 | 0.85 | SLC22A1 (0.92) | SLC22A1SLC22A2ALDH1A1TP53CYP3A4 | |
| Tetrabuthylammonium SCHEMBL3414877 | 0.85 | SLC22A1 (0.92) | SLC22A1SLC22A2ALDH1A1TP53CYP3A4 | |
| Tetrabuthylammonium SCHEMBL10352758 | 0.85 | SLC22A1 (0.92) | SLC22A1SLC22A2ALDH1A1TP53CYP3A4 | |
| Tetrabuthylammonium SCHEMBL29213158 | 0.85 | SLC22A1 (0.92) | SLC22A1SLC22A2ALDH1A1TP53CYP3A4 | |
| Tetrabuthylammonium SCHEMBL287249 | 0.83 | SLC22A1 (0.67) | SLC22A1SLC22A2ALDH1A1TP53CYP3A4 | |
| Tetrabuthylammonium SCHEMBL757474 | 0.83 | SLC22A1 (0.67) | SLC22A1SLC22A2ALDH1A1TP53CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 100 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117164875-A | Preparation method of tubular metal copper phthalocyanine polymer and cyclic carbonate | 浙江理工大学 | 2023-12-05 | — | — | CN | claimed |
| US-11603321-B2 | Rechargeable aluminum ion battery | EVERON24, INC. (US) | 2023-03-14 | — | — | US | claimed |
| WO-2023018641-A1 | METHODS FOR FORMING PEROVSKITE PHOTOVOLTAIC DEVICES | FIRST SOLAR, INC. (US) | 2023-02-16 | — | — | WO | claimed |
| EP-3077370-B1 | DEGRADABLE ISOCYANATE COMPOUNDS AND APPLICATIONS THEREOF | ADESSO ADVANCED MAT WUHU CO LTD (CN) | 2019-09-04 | — | — | EP | claimed |
| EP-3526878-A1 | RECHARGEABLE ALUMINUM ION BATTERY | Everon24 LLC (US) | 2019-08-21 | — | — | EP | claimed |
| US-10340150-B2 | Ni:NiGe:Ge selective etch formulations and method of using same | ENTEGRIS, INC. (US) | 2019-07-02 | — | — | US | claimed |
| US-20180138554-A1 | Rechargeable Aluminum Ion Battery | Alsym Energy, Inc. | 2018-05-17 | — | — | US | claimed |
| US-20170145001-A1 | PROCESSES FOR PREPARING BREXPIPRAZOLE | SCINOPHARM TAIWAN, LTD. (TW) | 2017-05-25 | — | — | US | claimed |
| WO-2017078621-A1 | PROCESSES FOR PREPARING BREXPIPRAZOLE | SCINOPHARM TAIWAN, LTD. (TW) | 2017-05-11 | — | — | WO | claimed |
| US-20160314990-A1 | NI:NIGE:GE SELECTIVE ETCH FORMULATIONS AND METHOD OF USING SAME | ENTEGRIS, INC. (US) | 2016-10-27 | — | — | US | claimed |
| WO-2015081610-A1 | DEGRADABLE ISOCYANATE COMPOUNDS AND APPLICATIONS THEREOF | ADESSO ADVANCED MATERIALS WUXI CO., LTD. (CN) | 2015-06-11 | — | — | WO | claimed |
| CN-103694140-A | Degradable isocyanate and application thereof | ADESSO ADVANCED MATERIALS WUXI CO LTD | 2014-04-02 | — | — | CN | claimed |
| EP-1434757-B1 | AMINONITRILE PRODUCTION | INVISTA TECH SARL (US) | 2006-12-20 | — | — | EP | claimed |
| CN-1280264-C | Aminonitrile production | DU PONT (CH) | 2006-10-18 | — | — | CN | claimed |
| CN-1564808-A | Aminonitrile production | DU PONT (US) | 2005-01-12 | — | — | CN | claimed |
| EP-1434757-A1 | AMINONITRILE PRODUCTION | INVISTA Technologies S.à.r.l. (US) | 2004-07-07 | — | — | EP | claimed |
| WO-2003029191-A1 | AMINONITRILE PRODUCTION | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2003-04-10 | — | — | WO | claimed |
| US-6506927-B1 | Aminonitrile production | E. I. DU PONT DE NEMOURS AND COMPANY | 2003-01-14 | — | — | US | claimed |
| US-4602080-A | POLYISOCYANURATES | SOCIETE CARBOCHIMIQUE EN ABREGE "CARBOCHIM" (BE) | 1986-07-22 | — | — | US | claimed |
| US-4544743-A | Salts of 1,3,5-oxadiazines-2,4,6-triones, 1,3,5-oxadiazines-2,4,6-triones and the preparation thereof | SOCIETE CARBOCHIMIQUE (BE) | 1985-10-01 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170145001-A1 | PROCESSES FOR PREPARING BREXPIPRAZOLE | CYP2B6, CYP2C19, CYP3A4 | SLC22A1 4348/4885SLC22A2 3952/4885ALDH1A1 310/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.